The Dow Jones Industrial Average ​rose ‌288.75 points, or 0.60%, to 48,731.16, ‍the S&P 500 gained 22.26 points, ⁠or 0.32%, to 6,932.05 and the Nasdaq Composite gained 51.46 points, or 0.22%, to ...

Tesla Under Investigation by U.S. Regulator for Model 3 Door Release Defects The Office of Defects Investigation at the NHTSA opened the investigation Wednesday after receiving a petition in late ...

Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...

Dynavax soared by 38.19 percent on Wednesday to close at $15.38 apiece as investors took heart from news that it was set to ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

The U.S. health landscape is undergoing significant transformations. Influential movements are shaping policies, market ...

Dynavax Technologies shares jumped more than 38% Wednesday after Sanofi announced a $15.50-per-share acquisition offer, valuing the company at roughly $2.2 billion.

French pharmaceutical giant Sanofi has announced plans to acquire U.S.-based biotech company Dynavax Technologies in a deal ...

The Dow Jones Industrial Average climbed 0.6% to 48,731.16, while the S&P 500 added 0.32% to close at 6,932.05.

NEW YORK (AP) — Wall Street was largely unchanged early Wednesday as markets hovered near record levels on a ...

Sanofi will pay $2.2 billion for Dynavax Techologies as it looks to add another Hepatitis B and new shingles vaccines to its portfolio.

Under the terms of the deal, Sanofi will begin a tender offer to purchase Dynavax's stock for $15.50 per share in cash. That values the biotech at roughly $2.2 billion, a premium of 39% compared to ...